Found 9 matching trials
Neoadjuvant RC48 Plus Gemcitabine in HER2-Expressing MIBC
PHASE3Objectives: To evaluate the non-inferiority of disitamab vedotin plus gemci...
Location
The First Affiliated Hospital of Anhui Medical University
A Study of RC48-ADC Combined With Toripalimab For First-line Treatment of Urothelial Carcinoma
PHASE3This is a Phase 3, Open-Label, Multicenter, Randomised, Controlled Study de...
Location
Cancer Hospital Chinese Academy of Medical Sciences
Study of Disitamab Vedotin Combined With Gemcitabine in Neoadjuvant Treatment of Urothelial Carcinoma
PHASE4A multicenter, open, single arm, phase II clinical trial was designed for m...
Location
Tongji Hospital affiliated to Tongji Medical College of Huazhong University of Science and Technology
Probiotics in Advanced Urothelial Carcinoma
PHASE2This is a multicenter, randomized, controlled phase II Study of evaluating ...
Location
Sun yat-sen university cancer center
RC48 Combined With Chemotherapy in HER2-Positive Advanced Breast Cancer Patients With Prior TOP1i-ADC Failure
PHASE2The purpose of this study is to assess the safety and efficacy of RC48 (a H...
Location
Multiple Locations
Disitamab Vedotin Plus Radiotherapy for Adjuvant Treatment of HER2-Expressing Cisplatin-Ineligible Upper Tract Urothelial Carcinoma
PHASE2This randomized, open-label, multicenter phase II study is designed to comp...
Location
Peking University First Hospital
HOPE-07-MIBC: Disitamab Vedotin Plus Immunotherapy vs Chemoimmunotherapy in Resectable HER2-Expressing MIBC
PHASE2This is a multicenter, randomized controlled clinical trial (HOPE-07) desig...
Location
Multiple Locations
PTC-guided Neoadjuvant Therapy For Muscle-invasive Bladder Cancer
PHASE2This study evaluates Patient-derived Tumor-like Cell Clusters (PTC)-guided ...
Location
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Disitamab Vedotin With Pembrolizumab vs Chemotherapy in Previously Untreated Urothelial Cancer Expressing HER2
PHASE3This study will enroll participants with urothelial cancer (UC). UC can inc...
Status
Active Not Recruiting
Location
Banner Gateway Medical Center